Weāre thrilled to announce Nanopathās expanded Leadership Team as we continue to drive development of our groundbreaking molecular diagnostic platform. Learn about their backgrounds and expertise in our latest announcement: prnewswire.com/news-releasesā¦
Help us welcome our two newest team members, George Roudebush and Minal Mardhani!
Check out the full post on LinkedIn.
linkedin.com/posts/nanopathdā¦
Nanopath retweeted
Dr. Amogha Tadimety, Co-Founder and CEO of portfolio company @nanopathdx, a trailblazing molecular diagnostics company focused on womenās health, recently sat down with AV CEO Mike Collins to discuss the company and her own entrepreneurial journey: av-funds.com/4bqOqpK
Our cofounders, Amogha Tadimety & Alison Burklund, recently spent the day at the Medtech Impact Symposium. They found it incredibly enriching to connect with visionaries & industry leaders. As a company, we're so lucky to be part of such a supportive community. Thanks, MassMEDIC!
Check out our Senior VP of Assay Development, Matthew Black, and Senior Scientist, Cameron Crawford, who represented Nanopath at Precision Med TRI-CON this week!
linkedin.com/posts/nanopathdā¦
On this International Women's Day, we're proud to be a part of a global movement that prioritizes and advances women's well-being through novel diagnostic solutions. Here's to progress, knowledge, and a healthier tomorrow for every woman.
Please join us in welcoming the newest additions to the Nanopath team; Fulya Ekiz Kanik and Henry Hwang!
More detail about their exciting backgrounds on LinkedIn!
linkedin.com/feed/update/urnā¦
As we look forward to 2024, weāve been reflecting on all the team has accomplished in 2023.
⢠Our team completed over 700 experiments.
⢠Our team grew to 12 full time employees.
⢠Awarded $1M from the National Science Foundation.
Excited to see what we will achieve in 2024!
Nanopath retweeted
#NSFSBIR startup @nanopathdx is empowering women and improving their health by using bioengineering and nanotechnology to detect human papillomavirus and urinary tract infections in minutes.
bit.ly/3GHCoLj
šø: Nanopath
We #welcome Monica Koubeck as Research Associate to Nanopath! She joins the team with experience in #assay development and optimizing for #pointofcare #diagnostics. We're excited about her shared passion for tackling #WomensHealth challenges, and to have her onboard!
Nanopath welcomes Josselyn and Noah as Summer 2023 Interns!
We are thrilled for them to join the team - looking forward to all we will accomplish together this summer!
Nanopath retweeted
The Massachusetts @StateOfPossible pavilion is buzzing on Day 3 of #BIO2023. Come learn about the worldās #1 #LifeSciences ecosystem. @MALifeSciences @MassBio @IAmBiotech #WeAreTheLifeSciences ā at Boston, MA
Nanopath co-founders are presenting at 2 special events today!
Amogha will be a pitch competition presenter at @Princeton Empower 2023. Alison will be representing Nanopath at @MassMEDICouncil Medtech Impact during a panel on "where we are going?" in women's health diagnostics.
Nanopath retweeted
After a break: the Empower 2023 Pitch Competition, at which six dynamic startups compete for $135,000 in cash prizes plus in-kind legal services: @nanopathdx, @Soliome1, Seia Bio, @herabiotech, @polygonesystems and AtomICs - plus an update from @SonaviLabs (5:30 pm ET 4/27)
Happy #InternationalWomensDay!
@nanopathdx was founded on the need to improve #WomensHealth - #empowering women everywhere to make #informed, timely decisions. We are proud to work each day with #women in mind.
Nanopath co-founders Amogha and Alison will be hosting the Northeast @_AACC chapter this Thursday for a seminar and tour at @enginexyz! We're looking forward to connecting with those in attendance.
More details on the event: eventcreate.com/e/february-1ā¦
We are thrilled to #welcome Uri Tayvah to the @nanopathdx team as Scientist! Uri comes to us with a #PhD in #chemistry - his dissertation focused on applications to #spectroscopy, modeling, and #dataanalysis. We are so happy to have him onboard!
We are so happy to #welcome Matt Black, PhD, to the Nanopath Team as VP of #AssayDevelopment. Matt comes to us with 10 years of #experience leading assay development for the development of #invitro #diagnostics, most recently for #COVID19 and #flu. Welcome to the team, Matt!
We'd like to extend a warm Nanopath welcome to Cassie Robinson, who joined us this week as #ResearchEngineer! Cassie joins the team with #engineering, #quality, and #clinical experience serving patients in #WomensHealth settings. We are so excited to have her onboard!
Happy Holidays from the Nanopath Team! Wishing you all the best in 2023 āļø
nanopathdx.com/



























